Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cipla
Deloitte
US Department of Justice
Novartis
Daiichi Sankyo
Fish and Richardson
Chinese Patent Office
Teva
Cerilliant

Generated: January 23, 2018

DrugPatentWatch Database Preview

MANNITOL Drug Profile

« Back to Dashboard

When do Mannitol patents expire, and what generic alternatives are available?

Mannitol is a drug marketed by B Braun, Hospira, Miles, Icu Medical Inc, Abraxis Pharm, Fresenius Kabi Usa, Igi Labs Inc, Intl Medication, Luitpold, Merck, and Watson Labs. and is included in fourteen NDAs.

The generic ingredient in MANNITOL is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.
Summary for MANNITOL
Drug patent expirations by year for MANNITOL
Medical Subject Heading (MeSH) Categories for MANNITOL

US Patents and Regulatory Information for MANNITOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc MANNITOL 5% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 019603-001 Jan 8, 1987 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs MANNITOL 25% mannitol INJECTABLE;INJECTION 087460-001 Jun 27, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12% mannitol INJECTABLE;INJECTION 016080-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 5% mannitol INJECTABLE;INJECTION 016080-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 10% mannitol INJECTABLE;INJECTION 016080-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc MANNITOL 20% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 019603-004 Jan 8, 1990 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Igi Labs Inc MANNITOL 25% mannitol INJECTABLE;INJECTION 089240-001 May 6, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 15% mannitol INJECTABLE;INJECTION 016080-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 10% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 020006-002 Jul 26, 1993 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45% mannitol INJECTABLE;INJECTION 016080-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
McKinsey
Daiichi Sankyo
Novartis
Baxter
Harvard Business School
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot